Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06138340
Other study ID # 20230808
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date August 31, 2023
Est. completion date December 31, 2025

Study information

Verified date November 2023
Source Beijing Tiantan Hospital
Contact Yuming Peng, MD,Ph.D
Phone 8610-59976658
Email florapym766@163.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Perioperative anesthesia can affect postoperative cognitive function. In our previous study, intraoperative dexmedetomidine (Dex) infusion reduced the incidence of delirium within the first 5 days after brain tumor. However, the mechanism is still unclear. With the development of neuroimaging, multimodal neuroimaging technology provide a new method to explore the underlying mechanism. Therefore, the purpose of this study is to analyze the alterations of brain network under sedation and anesthesia by different anesthetics in patients with supratentorial glioma and their association with cognition.


Recruitment information / eligibility

Status Recruiting
Enrollment 120
Est. completion date December 31, 2025
Est. primary completion date November 30, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Diagnosed as unilateral supratentorial glioma by MRI - Selective operation - Age over 18 years old - ASA I-II - Right handedness Exclusion Criteria: - History of cerebrovascular disease, brain trauma, chemotherapy and radiotherapy, or psychotropic drugs - History of intracranial surgery - Drug and/or alcohol abuse - History of dementia or mental illness - Pregnant or lactating women - Contraindications for MRI - Severe bradycardia (heart rate less than 40 beats per minute), sick sinus syndrome or second-to-third degree atrioventricular block - Severe hepatic or renal dysfunction

Study Design


Intervention

Drug:
Dexmedetomidine
Participants will be sedated and maintained by dexmedetomidine during the surgery.
Propofol
Participants will be sedated and maintained by propofol during the surgery.

Locations

Country Name City State
China Beijing Tian Tan Hospital, Capital Medical University Beijing Beijing

Sponsors (1)

Lead Sponsor Collaborator
Beijing Tiantan Hospital

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary The alterations of brain network connectivity. fMRI and DTI will be used to detect brain network connectivity. Before sedation, 30 minutes after sedation,and 30 minutes after surgery.
Secondary Postoperative delirium. The incidence and severity of postoperative delirium and its association with changes of brain network connectivity. Day 1-5 after surgery.
Secondary Electroencephalogram changes Electroencephalogram will be used to record the brain activity. From patients admission to operation room until 10 minutes after surgery
Secondary rScO2 changes. Regional cerebral oxygen saturation (rScO2) will be monitored with near-infrared spectroscopy (NIRS). From patients admission to operation room until 10 minutes after surgery
See also
  Status Clinical Trial Phase
Completed NCT03606941 - Effect of Electroacupuncture on the Incidence of Postoperative Delirium in Elderly Patients Undergoing the Major Surgery N/A
Recruiting NCT05990790 - The Effect of Desflurane Versus Sevoflurane Versus Propofol on Postoperative Delirium Phase 4
Completed NCT03950440 - Assessing the Incidence of Postoperative Delirium Following Aortic Valve Replacement
Terminated NCT03337282 - Incidence and Characteristics of Postoperative Cognitive Dysfunction in Elderly Quebec Francophone Patients
Completed NCT02585128 - Predictors of Postoperative Delirium After Transcatheter Aortic Valve Implantation N/A
Recruiting NCT02227225 - Factors Affecting the Incidence of Postoperative Delirium in Frail Elderly N/A
Recruiting NCT01934049 - Postoperative Recovery in Elderly Patients Undergoing Hip Hemi-arthroplasty Phase 4
Terminated NCT00455143 - Cognitive Protection - Dexmedetomidine and Cognitive Reserve Phase 4
Recruiting NCT05010148 - A Clinical Trial of Intravenous Lidocaine After Spinal Surgery to Prevent Delirium and Reduce Pain Phase 3
Completed NCT06178835 - EPO for Postop Delirium in Elderly Patients Phase 4
Recruiting NCT05992506 - Electroencephalographic Biomarker to Predict Postoperative Delirium
Recruiting NCT03839784 - Building a Platform for Precision Anesthesia in the Geriatric Surgical Patient
Completed NCT04154176 - Validation of the Greek Version of the Confusion Assessment Method Diagnostic Algorithm (CAM) and the Nursing Delirium Screening Scale (Nu-DESC) and Their Inter-rater Reliablity
Not yet recruiting NCT06375265 - Digital Sleep Optimization for Brain Health Outcomes in Older Surgical Patients N/A
Recruiting NCT05572307 - Peripheral Blood Single Cell Sequencing Analysis of POD and CPSP in Elderly Patients After Total Knee Arthroplasty
Active, not recruiting NCT03629262 - Dexmedetomidine Supplemented Intravenous Analgesia in Elderly After Orthopedic Surgery Phase 4
Not yet recruiting NCT05537155 - Buccal Acupuncture for Delirium Treatment in Older Patients Recovering From Orthopedic Surgery N/A
Completed NCT01964274 - Relevance of the Peripheral Cholinesterase-activity on Neurocognitive Dysfunctions in Surgical Patients
Completed NCT01599689 - Pilot and Feasibility Study of a Mirrors Intervention for Reducing Delirium in Older Cardiac Surgical Patients N/A
Active, not recruiting NCT03291626 - Postoperative Delirium: EEG Markers of Sleep and Wakefulness